Liminatus Pharma Goes Public Via SPAC
Biopharmaceutical company Liminatus Pharma LLC went public recently via a special purpose acquisition company, commonly known as a SPAC. Liminatus merged with blank check company Iris Acquisition Corp. in April to create a newly combined company called Liminatus Pharma Inc. “Today is a big day for our company. We are Read More







